Clinical Trials Education for Improving KAP

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if educating people about clinical trials can increase their understanding and willingness to participate. Participants will engage in the Clinical Trials Education Program, led by Community Health Educators who provide information on the importance of clinical trials. It suits English or Spanish speakers living in the Tampa Bay Area who can give informed consent. As an unphased trial, this study offers a unique opportunity to enhance knowledge about clinical trials and contribute to improving community awareness.

Do I need to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this education program is safe?

Research has shown that education programs about clinical trials focus on explaining how these trials work and why they are important. These programs remain safe because they are educational, not medical treatments.

Attending these programs resembles going to a class or seminar. No reports of physical side effects exist because participants do not take any medicine or undergo medical procedures. The goal is to help participants understand and learn more about participating in clinical trials.

Overall, these education programs are well-received because they provide information, not medical treatments.12345

Why are researchers excited about this trial?

Researchers are excited about the Clinical Trials Education Program because it focuses on boosting knowledge and awareness about clinical trials themselves, rather than a specific medical condition. Unlike other educational methods that might only touch on the basics, this program leverages Community Health Educators to provide in-depth education on the significance and process of participating in clinical trials. This personalized approach aims to empower individuals with a better understanding, potentially leading to higher participation rates and more diverse trial populations, which can ultimately improve the development of new treatments.

What evidence suggests that this education program is effective for increasing knowledge of clinical trials?

Research has shown that education programs about clinical trials can greatly increase knowledge and understanding. In this trial, participants will receive education through the Clinical Trials Education Program, which aims to enhance awareness and comfort with clinical trial participation. Studies have found that structured learning about clinical trials increases awareness and comfort with participation. This education explains the purpose, benefits, and possible risks of clinical trials, enabling better decision-making about joining a trial. Additionally, informed participants can improve the quality of clinical research by providing better feedback and staying engaged.678910

Who Is on the Research Team?

CK

Clement K Gwede, PhD, MPH, RN, FAAN

Principal Investigator

Moffitt Cancer Center

Are You a Good Fit for This Trial?

This trial is for English or Spanish speakers who can give informed consent and live in the Tampa Bay Area (Hillsborough, Pinellas, Polk, or Pasco county). It's not specified who cannot participate.

Inclusion Criteria

Able to provide informed consent
Reside in the Tampa Bay Area (Hillsborough, Pinellas, Polk or Pasco county)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Education Intervention

Community Health Educators provide Clinical Trial Education to increase knowledge of Clinical Trials and the importance of Clinical Trial participation

1 day
1 visit (in-person)

Follow-up

Participants are monitored for changes in knowledge and beliefs about clinical trials after the educational intervention

Immediately after intervention

What Are the Treatments Tested in This Trial?

Interventions

  • Clinical Trials Education Program
Trial Overview The study is testing a Clinical Trials Education Program to see if it effectively increases understanding and participation in clinical trials among participants.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Clinical Trials EducationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

H. Lee Moffitt Cancer Center and Research Institute

Lead Sponsor

Trials
576
Recruited
145,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

The implementation of a computerized data management system for clinical trials significantly reduced transcription errors and overlooked adverse events, with errors dropping from 17% to 0% and overlooked events from 35% to 3%.
Using the computerized system also decreased the time needed to evaluate clinical information and report adverse events by 2-4 months, enhancing compliance with regulations and allowing for quicker identification of potential risks to patients.
Evaluation of benefits derived from a computerized data management system for clinical trials data.Elting, LS., Bodey, GP.[2018]
A survey of 509 clinical research associates (CRAs) and research nurses (RNs) revealed significant variability in adverse event (AE) reporting practices, with only 51.2% using standardized methods, highlighting a need for improved training and consistency.
Respondents identified major challenges in AE reporting, such as differences in trial protocols and definitions, and expressed strong support for additional resources like online reporting modules and standardized tracking forms to enhance reporting accuracy.
Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report.Miller, TP., Marx, MZ., Henchen, C., et al.[2023]
A new tool for clinicians in inpatient oncology units has been developed to prevent adverse events and enhance patient safety, focusing specifically on cancer patients.
The tool includes a catalog of adverse events and a risk map, which helps healthcare providers implement best practices in their daily activities to improve clinical safety.
Improving patient safety in the inpatient setting through risk assessment and mitigation.Reche Navarro, MN.[2016]

Citations

Study Details | NCT02274818 | Individualized Comparative ...The main protocol will examine patient safety and costs as well as quality of education. The "Time and Motion" substudy examines additional educational outcomes ...
Evaluating the effectiveness of undergraduate clinical ...Medical schools should use a variety of measures to evaluate the effectiveness of their clinical curricula. Both outcome measures and process measures should ...
Research We FundPCORI funds patient-centered comparative clinical effectiveness research (CER) and CER-related projects.
The impact of patient-reported outcome (PRO) data from ...PRO trial data may potentially lead to a range of benefits for patients and society, which can be measured through appropriate impact metrics.
Real-world data: bridging the gap between clinical trials ...We explore the challenges of RWD and discuss key questions that clinicians, patients, and regulators will need to consider when faced with positive efficacy ...
Clinical Trials Design and ManagementIdentify the role biostatistics plays in designing the clinical protocol and evaluating the resulting safety and efficacy data. Clinical Trials Design and ...
Pre-Marketing Clinical Trial SafetyThe module covers drug safety requirements, ethical safeguards, informed consent, review boards, data safety, reporting, risk assessment, and pre-marketing ...
Data Safety and Monitoring Boards for Clinical TrialsUpon completion of the course you will have gained an understanding of: What a Data Safety Monitoring Board does; The existing regulations and where the gaps ...
9.about.citiprogram.orgabout.citiprogram.org/
Research, Ethics, Compliance, and Safety TrainingCITI Program provides training courses for colleges and universities, healthcare institutions, technology and research organizations, and governmental ...
Guidelines for Data and Safety Monitoring of Clinical TrialsThe National Eye Institute (NEI) has established the following guidelines for the appropriate oversight and monitoring of the conduct of clinical trials.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security